Ember Therapeutics, Inc. (EMBT)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2014 | -17.42 Thousand USD | -57.27% |
| 2013 | -11.07 Thousand USD | -40.77% |
| 2012 | -7869.00 USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2015 Q2 | -5844.00 USD | -54.2% |
| 2015 Q3 | 252.00 USD | 104.31% |
| 2015 Q1 | -3790.00 USD | 16.67% |
| 2014 Q1 | -2898.00 USD | 28.41% |
| 2014 FY | - USD | -57.27% |
| 2014 Q4 | -4548.00 USD | -15.93% |
| 2014 Q3 | -3923.00 USD | 35.18% |
| 2014 Q2 | -6052.00 USD | -108.83% |
| 2013 FY | - USD | -40.77% |
| 2013 Q4 | -4048.00 USD | -4.79% |
| 2013 Q1 | -1816.00 USD | 0.0% |
| 2013 Q2 | -1350.00 USD | 25.66% |
| 2013 Q3 | -3863.00 USD | -186.15% |
| 2012 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -71.03 Million USD | 99.975% |
| Nanobac Pharmaceuticals, Incorporated | -5.92 Million USD | 99.706% |
| SQZ Biotechnologies Company | -64.14 Million USD | 99.973% |
| Evofem Biosciences, Inc. | -17.37 Million USD | 99.9% |
| Santhera Pharmaceuticals Holding AG | 94.03 Million USD | 100.019% |
| Mesoblast Limited | -62.38 Million USD | 99.972% |
| Propanc Biopharma, Inc. | -1.53 Million USD | 98.866% |
| Genus plc | 73.7 Million USD | 100.024% |
| VioQuest Pharmaceuticals, Inc. | -6.61 Million USD | 99.737% |
| CNBX Pharmaceuticals Inc. | -3.54 Million USD | 99.509% |
| Marizyme, Inc. | -34.28 Million USD | 99.949% |
| ContraFect Corporation | -64.99 Million USD | 99.973% |
| Nymox Pharmaceutical Corporation | -8.77 Million USD | 99.801% |
| PsyBio Therapeutics Corp. | -4.52 Million USD | 99.615% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | 98.757% |
| Intellipharmaceutics International Inc. | -2.64 Million USD | 99.341% |
| AXIM Biotechnologies, Inc. | -2.32 Million USD | 99.25% |
| MultiCell Technologies, Inc. | -518.04 Thousand USD | 96.637% |
| Accustem Sciences Inc. | -3.74 Million USD | 99.535% |
| RVL Pharmaceuticals plc | -48.22 Million USD | 99.964% |
| EV Biologics, Inc. | -1.26 Million USD | 98.625% |
| Q BioMed Inc. | -617.62 Thousand USD | 97.179% |
| Emmaus Life Sciences, Inc. | 3.57 Million USD | 100.488% |
| Neon Bloom, Inc. | -632.4 Thousand USD | 97.245% |
| Mosaic ImmunoEngineering Inc. | -2.28 Million USD | 99.237% |
| Biomind Labs Inc. | -1.03 Million USD | 98.316% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | 9.87 Million USD | 100.176% |
| Oncotelic Therapeutics, Inc. | -7.16 Million USD | 99.757% |
| Skye Bioscience, Inc. | -13.54 Million USD | 99.871% |
| Therapeutic Solutions International, Inc. | -1.48 Million USD | 98.829% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | 30.316% |
| Arch Therapeutics, Inc. | -3.88 Million USD | 99.552% |
| IMV Inc. | -35.52 Million USD | 99.951% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | 99.89% |
| Curative Biotechnology, Inc. | -2.5 Million USD | 99.304% |
| GB Sciences, Inc. | -1.41 Million USD | 98.773% |
| Alpha Cognition Inc. | -9.7 Million USD | 99.821% |
| HST Global, Inc. | -5303.00 USD | -228.512% |
| CSL Limited | 4.78 Billion USD | 100.0% |
| Halberd Corporation | -74.27 Thousand USD | 76.547% |
| Enzolytics Inc. | -2.12 Million USD | 99.179% |
| Resverlogix Corp. | -11.74 Million USD | 99.852% |
| Affymax, Inc. | -14.29 Million USD | 99.878% |
| SYBLEU INC | -141.57 Thousand USD | 87.695% |
| Nuo Therapeutics, Inc. | -3.06 Million USD | 99.431% |
| argenx SE | -216.02 Million USD | 99.992% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -55.33 Million USD | 99.969% |
| Enzon Pharmaceuticals, Inc. | 1.21 Million USD | 101.431% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -1.49 Million USD | 98.838% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | 378.84 Thousand USD | 104.598% |
| AVAX Technologies, Inc. | -6.11 Million USD | 99.715% |
| Zenith Capital Corp. | -8.6 Million USD | 99.798% |
| Genscript Biotech Corporation | -248.71 Million USD | 99.993% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.44 Million USD | 99.288% |
| WPD Pharmaceuticals Inc. | -176.02 Thousand USD | 90.103% |
| American Oriental Bioengineering, Inc. | -39.63 Million USD | 99.956% |
| Provectus Biopharmaceuticals, Inc. | -2.89 Million USD | 99.398% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -1.04 Million USD | 98.335% |
| GlobeStar Therapeutics Corporation | 6724.00 USD | 359.087% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.74 Million USD | 99.005% |
| Cotinga Pharmaceuticals Inc. | -1.92 Million USD | 99.093% |
| BioStem Technologies, Inc. | -7.55 Million USD | 99.769% |
| ONE Bio Corp. | 13.61 Million USD | 100.128% |
| Reve Technologies, Inc. | -181.08 Thousand USD | 90.38% |
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| Wesana Health Holdings Inc. | -2.05 Million USD | 99.153% |
| Agentix Corp. | -1.37 Million USD | 98.73% |
| LadRx Corporation | 412.28 Thousand USD | 104.225% |
| Cell Source, Inc. | -4.27 Million USD | 99.592% |
| ProtoKinetix, Incorporated | -367.22 Thousand USD | 95.256% |
| Regen BioPharma, Inc. | 1.46 Million USD | 101.188% |
| Regen BioPharma, Inc. | -936.94 Thousand USD | 98.141% |
| NovAccess Global Inc. | -1.03 Million USD | 98.316% |
| Endonovo Therapeutics, Inc. | 8.85 Million USD | 100.197% |
| Itoco Inc. | -1.86 Million USD | 99.068% |
| Rasna Therapeutics, Inc. | -379.62 Thousand USD | 95.411% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | 98.439% |
| Kadimastem Ltd | -2.62 Million USD | 99.336% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -239.15 Thousand USD | 92.715% |
| CytoDyn Inc. | -18.02 Million USD | 99.903% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.02 Thousand USD | 77.956% |
| Mobile Lads Corp. | -2.24 Million USD | 99.223% |
| NanoSphere Health Sciences Inc. | -12.22 Thousand USD | -42.456% |
| Qrons Inc. | -40.08 Thousand USD | 56.536% |
| Alseres Pharmaceuticals, Inc. | -485.67 Thousand USD | 96.413% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | 527.43 Thousand USD | 103.303% |
| Rebus Holdings, Inc. | -951 Thousand USD | 98.168% |
| ImmunoCellular Therapeutics, Ltd. | -1.06 Million USD | 98.36% |
| International Stem Cell Corporation | 202 Thousand USD | 108.624% |
| Bioxytran, Inc. | -3.82 Million USD | 99.544% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | 66.905% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.46 Million USD | 99.292% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -35.86 Million USD | 99.951% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -45 Thousand USD | 61.287% |
| Innovation Pharmaceuticals Inc. | -2.73 Million USD | 99.364% |
| Neutra Corp. | -181.24 Thousand USD | 90.388% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | 99.914% |
| PureTech Health plc | -11.62 Million USD | 99.85% |
| Coeptis Therapeutics, Inc. | -20.15 Million USD | 99.914% |
| IXICO plc | -707 Thousand USD | 97.536% |
| IntelGenx Technologies Corp. | -7.68 Million USD | 99.773% |
| Gelesis Holdings, Inc. | -48.34 Million USD | 99.964% |
| CSL Limited | 4.73 Billion USD | 100.0% |
| Cellectis S.A. | -92.63 Million USD | 99.981% |